In summary, enalapril significantly mitigated multiple pathological markers associated with aging, including lipid droplets, amyloid, glycogen deposition, and fibrosis, in the brain, kidneys, liver, ...
Research reports from Morningstar & Argus help you make better investment decisions. Leverage these to understand future stock performance and identify high performing investment ideas.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback